GNH USA

Europe — EMA

Paliperidon Starterpackung Genericon (Paliperidone Palmitate)

GNH USA supplies Paliperidon Starterpackung Genericon (Paliperidone Palmitate), a long‑acting atypical antipsychotic for schizophrenia and schizoaffective

Paliperidone Palmitate

Request sourcing

1
Pack/s

What is Paliperidone Palmitate?

Paliperidone Palmitate, the active ingredient in Paliperidon Starterpackung Genericon, is a long‑acting atypical antipsychotic presented as a depot injection for intramuscular use. It is indicated for the maintenance treatment of schizophrenia and schizoaffective disorder in adult patients. GNH USA supplies Paliperidon Starterpackung Genericon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Paliperidone Palmitate used for?

Paliperidone palmitate is used in the management of psychotic disorders that require long‑term maintenance therapy. - Schizophrenia: provides sustained symptom control and reduces relapse risk. - Schizoaffective disorder: maintains mood stability and psychotic symptom control. - Maintenance therapy after acute stabilization: allows once‑monthly dosing to improve adherence.

What are the side effects of Paliperidone Palmitate?

Paliperidone palmitate may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Injection site pain or induration: mild discomfort at the injection site. - Weight gain: gradual increase in body weight. - Akathisia: inner restlessness or inability to stay still. - Somnolence: drowsiness or fatigue. - Hyperprolactinemia: elevated prolactin levels leading to menstrual changes. - Constipation: reduced bowel motility.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and muscle rigidity. - Tardive dyskinesia: persistent involuntary movements. - Seizures: increased risk in predisposed individuals. - Orthostatic hypotension: sudden drop in blood pressure on standing.

What precautions apply to Paliperidone Palmitate?

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks. - Cardiovascular assessment: check for QT prolongation or arrhythmias. - Metabolic monitoring: regularly assess weight, glucose, and lipid profile. - Prolactin levels: monitor for galactorrhea or menstrual disturbances. - Pregnancy and lactation: avoid use unless benefits outweigh risks. - Elderly patients: start with lower doses and observe for sedation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

What does Paliperidone Palmitate interact with?

Paliperidone palmitate can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., carbamazepine, rifampin): may reduce plasma concentrations. - QT‑prolonging agents (e.g., quinidine, haloperidol): increase risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): may enhance sedation. - Anticholinergic drugs (e.g., diphenhydramine): may worsen cognitive side effects. - Antihypertensives: additive orthostatic hypotension. - Lithium: monitor for neurotoxicity.

Frequently asked questions

What conditions is Paliperidon Starterpackung Genericon used for?+
Paliperidon Starterpackung Genericon contains paliperidone palmitate, which is approved for the maintenance treatment of schizophrenia and schizoaffective disorder in adult patients. It helps reduce relapse risk by providing steady plasma levels through monthly intramuscular injections.
How does paliperidone palmitate work in the body?+
Paliperidone palmitate acts as an antagonist at dopamine D2 and serotonin 5‑HT2A receptors. By blocking D2 receptors in key brain pathways it diminishes positive psychotic symptoms, while 5‑HT2A antagonism balances dopamine activity and reduces motor side effects. The palmitate ester forms a depot that releases the drug slowly over weeks.
What is the usual dose of Paliperidon Starterpackung Genericon?+
The exact dosing regimen is determined by the prescribing clinician based on the patient’s clinical status, prior response, and tolerability. Doses are individualized and administered as a monthly intramuscular injection according to the product’s prescribing information.
Is Paliperidon Starterpackung Genericon safe during pregnancy or breastfeeding?+
Paliperidone palmitate is classified as a pregnancy category C medication. It should only be used if the potential benefit justifies the potential risk to the fetus. Breastfeeding is not recommended because the drug is excreted in milk and may affect the infant. Consultation with a healthcare professional is essential.
How do I order Paliperidon Starterpackung Genericon from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.
How does paliperidone palmitate compare with other long‑acting antipsychotics?+
Paliperidone palmitate offers once‑monthly dosing similar to other depot formulations like risperidone microspheres or aripiprazole monohydrate. Its receptor profile provides strong D2 antagonism with additional 5‑HT2A blockade, which may result in a different side‑effect balance, particularly regarding prolactin elevation and metabolic effects.
What are the storage requirements for Paliperidon Starterpackung Genericon?+
The product must be stored refrigerated at 2‑8 °C. Keep it in the original packaging, protect it from light, and avoid freezing or shaking the vial. Do not store at room temperature for extended periods, as stability may be compromised.
How is Paliperidon Starterpackung Genericon administered?+
Paliperidon Starterpackung Genericon is given as an intramuscular injection, typically into the deltoid or gluteal muscle. The injection is performed by a qualified healthcare professional using aseptic technique. The dosing interval is usually once every four weeks after the initial loading phase.
What are the most serious risks associated with paliperidone palmitate?+
Serious adverse events include neuroleptic malignant syndrome, tardive dyskinesia, seizures, and significant orthostatic hypotension. Patients should be monitored for signs of fever, muscle rigidity, involuntary movements, or sudden drops in blood pressure, and the medication should be discontinued if these occur.
Who should not use Paliperidon Starterpackung Genericon?+
Patients with known hypersensitivity to paliperidone, its excipients, or any component of the formulation should avoid use. Caution is also advised for individuals with uncontrolled cardiovascular disease, severe hepatic impairment, or a history of neuroleptic malignant syndrome.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Paliperidone Palmitate
Route
Intramuscular Use
Manufacturer
Genericon Pharma Gesellschaft M.B.H.
Origin
EU

Related products

Arion

Arion

Paliperidone Palmitate

Belupo D.D.
EU
Baceq

Baceq

Paliperidone Palmitate

Abz-Pharma Gmbh
EU
Baceq

Baceq

Paliperidone Palmitate

Teva Pharma S.L.U.,
EU
Byannli

Byannli

Paliperidone Palmitate

Janssen-Cilag International Nv
EU